[1] POSTWHITE J, LADASE J, KELLY K M. Advances in the use of milk thistle (Silybum marianum)[J]. Integrative Cancer Therapies,2007,6(2):104-109.
[2] 安咏梅.水飞蓟的经济价值和栽培技术[J].北方园艺,2014,30(16):161-163.
[3] 徐德峰,张卫明,史劲松,等.国内水飞蓟资源利用现状与展望[J].食品研究与开发,2007,28(2):157-161.
[4] 朱淑云.水飞蓟籽仁蛋白和油的主要特性与生物活性研究[D].镇江:江苏大学,2013:7-8.
[5] 刘宏.水飞蓟种子活性成分的提取、分离及初步活性研究[D].北京:北京化工大学,2009:19-20.
[6] SIEGEL A B, STEBBING J. Milk thistle: early seeds of potential[J]. The Lancet Oncology, 2013, 14 (10): 929-930.
[7] CUFI S, BONAVIA R, VAZQUEZMARTIN A, et al. Silibinin meglumine, a watersoluble form of milk thistle silymarin, is an orally active anticancer agent that impedes the epithelialtomesenchymal transition (EMT) in EGFRmutant nonsmallcell lung carcinoma cells[J].Food and Chemical Toxicology, 2013, 60(10):360-368.
[8] KROLL D J, SHAW H S, OBERLIES N H. Milk thistle nomenclature: Why it matters in cancer research and pharmacokinetic studies[J]. Integrative Cancer Therapies 2007, 6 (2): 110-119.
[9] 王红军,姜媛媛,路平,等.水飞蓟宾的抗肿瘤、抗氧化和免疫调节分子药理学机制研究进展[J].药学学报,2010,45(4):413-421.
[10] ESPOSITO M, DIPIERRO P, DEJONGHE W, et al. Enzymatic milk clotting activity in artichoke (Cynara scolymus) leaves and alpine thistle (Carduus defloratus) flowers. Immobilization of alpine thistle aspartic protease[J]. Food Chemistry, 2016, 204:115-121.